share_log
Moomoo 24/7 ·  2023/11/07 07:17

ADC Therapeutics Sees Continued Decrease In Total Operating Expenses In FY23 And FY24 As Compared to FY22; Expected Cash Runway Into Middle of 2025

ADC Therapeutics预计,与22财年相比,23财年和24财年的总运营支出将继续减少;预计现金流将持续到2025年中期

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发